Rabies Vaccine for Human Use(Vero cell，Liaoning Chengda)

冻干人用狂犬病疫苗（Vero细胞，辽宁成大）

Report date: 2022/10/18 16:36:39

Base Information

Drug NameRabies Vaccine for Human Use(Vero cell，Liaoning Chengda)
Drug Alias NameChromatographically purified rabies vaccine - Liaoning ChengDa BiotechnologyPerfusion cell culture based rabies vaccine - Liaoning ChengDa BiotechnologyPurified Vero cell rabies vaccine - Liaoning ChengDa BiotechnologyVero cell derived rabies vaccine - Liaoning ChengDa BiotechnologyTRCS CPRV - Liaoning ChengDa Biotechnology +[9] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRabies
Global Approved IndicationsRabies
Approved Indications in ChinaRabies
Original Approved Country/TerritoryMainland China
Original Approved Date2004/12/22
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLiaoning Chengda Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Chengda Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsRabies
Inactive IndicationsN/A

Other Information

ATC CodeJ07BG01
Related LinksN/A